Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.18%
#3 CoW Protocol CoW Protocol +41.66%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +25.34%
#6 Walrus Walrus +23.68%
#7 Codatta Codatta +19.58%
#8 Enso Enso +18.19%
#9 The Black Bull The Black Bull +15.04%
#10 Collector Crypt Collector Crypt +14.18%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Lysogene S.A. Lysogene S.A.

Lysogene S.A.

LYS
주식 순위 #36618
Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy,... Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy, dedicated to discovering and advancing treatments for children affected by severe neurodegenerative lysosomal storage disorders. Its development pipeline includes LYS-SAF302, which is currently undergoing Phase II/III clinical trials for mucopolysaccharidosis type IIIA (MPS IIIA). Another promising candidate, LYS-GM101, is in Phase I/II development, targeting GM1 gangliosidosis. The company has also forged a research alliance with the Weizmann Institute of Science to pioneer novel adeno-associated virus (AAV) gene therapy approaches for conditions such as neuronopathic Gaucher disease, Parkinson's disease, and other related illnesses. Lysogene S.A. was established in 2009 and is headquartered in Neuilly-sur-Seine, France.
주가
$0.30221445
마지막 동기화: 2023-05-22
시가총액
$2.49M
변동 (1일)
-0.10%
변동 (1년)
0.00%
국가
FR
거래 Lysogene S.A. (LYS)

카테고리

Healthcare
Lysogene S.A. (LYS)의 주가 이력
최고 종가: $0.31 (2023-05-01 기준)

최저 종가: $6.58 (2017-02-01 기준)
Lysogene S.A.의 주가 이력 (2017 ~ 2026)
연간 주가 성과
연도 성과
2023 -33.14%
2022 -79.09%
2021 -20.07%
2020 47.25%
2019 3.66%
2018 -62.69%
2017 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE